kabutan

M3, Inc.(2413) Summary

2413
TSE Prime
M3, Inc.
1,902.5
JPY
-50.5
(-2.59%)
Jan 29, 3:11 pm JST
12.42
USD
Jan 29, 1:12 am EST
Result
PTS
outside of trading hours
1,902.9
Jan 29, 3:12 pm JST
Summary Chart Historical News Financial Result
PER
28.6
PBR
3.33
Yield
ー%
Margin Trading Ratio
13.36
Stock Price
Jan 29, 2026
Opening Jan 29, 9:03 am
1,900.0 JPY 12.40 USD
Previous Close Jan 28
1,953.0 JPY 12.79 USD
High Jan 29, 9:03 am
1,913.0 JPY 12.49 USD
Low Jan 29, 12:55 pm
1,875.5 JPY 12.26 USD
Volume
2,527,000
Trading Value
4.78B JPY 0.03B USD
VWAP
1891.81 JPY 12.36 USD
Minimum Trading Value
190,250 JPY 1,242 USD
Market Cap
1.29T JPY 8.44B USD
Number of Trades
6,454
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
High
1-Year Average
8,497
1-Year High Aug 7, 2025
48,319
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 221,100 3,835,000 17.35
Jan 16, 2026 216,200 3,559,100 16.46
Jan 9, 2026 221,000 3,519,600 15.93
Dec 26, 2025 270,600 4,015,300 14.84
Dec 19, 2025 291,200 3,927,000 13.49
Company Profile
M3, Inc. is a Sony Group affiliate specializing in pharmaceutical marketing support. It provides information through a website for physicians and is also involved in telemedicine.
Sector
Services
M3, Inc., a member of the Sony Group, aims to revolutionize the medical world through the use of the internet. The company operates various services both domestically and internationally, centered around its professional medical website "m3.com". Its main business activities include marketing support for medical-related companies, surveys targeting healthcare professionals, practice management services, clinical trial support, CSO operations, and the development and sale of electronic medical records. M3 also engages in evidence solution services such as clinical development support, clinical trial management and operational support, and subject recruitment assistance. Additionally, the company provides human resource services for medical professionals, management support for medical institutions, and operates hospice facilities. Internationally, M3 has expanded its operations globally, offering marketing support, surveys, human resource services for medical professionals, and clinical trial support.